Atea Pharmaceuticals (AVIR) Stock Chart & Stock Price History $3.22 -0.09 (-2.72%) (As of 11/15/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Atea Pharmaceuticals Stock Price Performance 5 Day Performance-3.30%1 Month Performance-13.67%3 Month Performance-12.50%6 Month Performance-11.78%Year-To-Date Performance+5.57%1 Year Performance+6.27% Receive AVIR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Atea Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Let’s be blunt (Ad)Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)! Check out the $100 Challenge now AVIR Stock Chart for Sunday, November, 17, 2024 AVIR Chart by TradingView Atea Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/15/2024$3.31$3.22-2.72%$3.35$3.18313,820 shs$271.97 million11/14/2024$3.35$3.31-1.19%$3.43$3.31208,898 shs$279.56 million11/13/2024$3.33$3.35+0.60%$3.48$3.35207,985 shs$282.94 million11/12/2024$3.36$3.33-0.89%$3.43$3.32265,329 shs$281.12 million11/11/2024$3.50$3.36-4.00%$3.55$3.33243,301 shs$283.65 million11/08/2024$3.44$3.50+1.74%$3.57$3.43170,075 shs$295.47 million Get the Latest News and Ratings for AVIR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Atea Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/07/2024$3.58$3.44-3.91%$3.60$3.41282,101 shs$290.41 million11/06/2024$3.36$3.58+6.55%$3.62$3.43380,021 shs$302.22 million11/05/2024$3.35$3.36+0.30%$3.37$3.2993,437 shs$283.65 million11/04/2024$3.29$3.35+1.82%$3.40$3.25137,566 shs$282.81 million11/01/2024$3.24$3.29+1.54%$3.31$3.2577,369 shs$277.74 million10/31/2024$3.28$3.24-1.22%$3.31$3.22193,233 shs$273.53 million10/30/2024$3.39$3.28-3.24%$3.45$3.28125,189 shs$276.90 million10/29/2024$3.42$3.39-0.88%$3.43$3.34119,373 shs$285.52 million10/28/2024$3.35$3.42+2.09%$3.48$3.36115,346 shs$288.04 million10/25/2024$3.38$3.35-0.89%$3.45$3.3586,513 shs$282.15 million10/24/2024$3.48$3.38-2.87%$3.53$3.30154,741 shs$284.67 million10/23/2024$3.56$3.48-2.25%$3.56$3.4099,896 shs$293.10 million10/22/2024$3.59$3.56-0.84%$3.60$3.5152,247 shs$299.83 million10/21/2024$3.82$3.59-6.02%$3.86$3.59180,428 shs$302.36 million10/18/2024$3.73$3.82+2.41%$3.84$3.70157,455 shs$321.73 million10/17/2024$3.77$3.73-1.06%$3.79$3.71115,899 shs$314.15 million10/16/2024$3.55$3.77+6.20%$3.80$3.55250,249 shs$317.52 million Related Companies Inovio Pharmaceuticals Stock Price Chart Bicycle Therapeutics Stock Price Chart ArriVent BioPharma Stock Price Chart Ardelyx Stock Price Chart Phibro Animal Health Stock Price Chart Immatics Stock Price Chart Collegium Pharmaceutical Stock Price Chart Septerna Stock Price Chart CARGO Therapeutics Stock Price Chart Prothena Stock Price Chart Receive AVIR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Atea Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AVIR) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atea Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Atea Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
